Search Results - "Tufton, Nicola"
-
1
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
Published in Nature reviews. Endocrinology (01-07-2021)“…Approximately 20% of patients diagnosed with a phaeochromocytoma or paraganglioma carry a germline mutation in one of the succinate dehydrogenase ( SDHx )…”
Get full text
Journal Article -
2
Can subunit‐specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?
Published in Clinical endocrinology (Oxford) (01-01-2019)“…Summary Objective With the discovery that familial phaeochromocytoma and paraganglioma syndrome can be caused by mutations in each subunit of the succinate…”
Get full text
Journal Article -
3
Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers
Published in Journal of the Endocrine Society (01-07-2017)“…There has been a significant increase in the availability of testing for pheochromocytoma and paraganglioma (PPGL) germline susceptibility genes. As more…”
Get full text
Journal Article -
4
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
Published in Clinical epigenetics (20-12-2023)“…Phaeochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours. Pathogenic variants have been identified in more than 15 susceptibility genes;…”
Get full text
Journal Article -
5
First-positive surveillance screening in an asymptomatic SDHA germline mutation carrier
Published in Endocrinology, diabetes & metabolism case reports (30-05-2019)“…Summary At least 40% of phaeochromocytomas and paraganglioma’s (PPGLs) are associated with an underlying genetic mutation. The understanding of the genetic…”
Get full text
Journal Article -
6
A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
Published in Endocrinology, diabetes & metabolism case reports (21-07-2018)“…Summary Symptomatic pituitary adenomas occur with a prevalence of approximately 0.1% in the general population. It is estimated that 5% of pituitary adenomas…”
Get full text
Journal Article -
7
An analysis of surveillance screening for SDHB-related disease in childhood and adolescence
Published in Endocrine Connections (01-03-2019)“…Objective Phaeochromocytomas (PCC) and paragangliomas (PGL) are rare in children. A large proportion of these are now understood to be due to underlying…”
Get full text
Journal Article -
8
Prevalence of Diabetes on Santa Cruz Island in Galapagos Archipelago
Published in Preventing chronic disease (18-06-2015)“…This was an observational study offering a screening program for diabetes in a health clinic in Puerto Ayora town on Santa Cruz Island to determine the…”
Get full text
Journal Article -
9
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Published in European journal of cancer (1990) (01-03-2021)“…Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission…”
Get full text
Journal Article -
10
Diffusion‐weighted imaging (DWI) highlights SDHB‐related tumours: A pilot study
Published in Clinical endocrinology (Oxford) (01-07-2019)“…Objective There is consensus that asymptomatic carriers of SDHB mutations should undergo periodic surveillance imaging. MRI has the advantage of avoiding…”
Get full text
Journal Article -
11
Excluding the pheochromocytoma
Published in International journal of cardiology (15-12-2017)Get full text
Journal Article -
12
The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas
Published in Endocrine-related cancer (01-11-2022)“…Emerging evidence suggests the composition of the tumour microenvironment (TME) correlates with clinical outcome and that each tumour type has a unique TME…”
Get full text
Journal Article -
13
Pituitary Carcinoma in a Patient with an SDHB Mutation
Published in Endocrine pathology (01-12-2017)“…We present the first case of pituitary carcinoma occurring in a patient with a succinate dehydrogenase subunit B (SDHB) mutation and history of paraganglioma…”
Get full text
Journal Article -
14
SDHA mutated paragangliomas may be at high risk of metastasis
Published in Endocrine-related cancer (01-07-2017)Get full text
Journal Article -
15
Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers
Published in Clinical endocrinology (Oxford) (01-02-2017)“…Summary Objective For ‘asymptomatic carriers’ of the succinate dehydrogenase subunit B (SDHB) gene mutations, there is currently no consensus as to the…”
Get full text
Journal Article -
16
Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort
Published in Clinical endocrinology (Oxford) (01-10-2022)“…Objectives Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours with malignant potential and a hereditary basis in almost 40% of…”
Get full text
Journal Article -
17
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature
Published in The lancet. Diabetes & endocrinology (01-01-2021)“…Phaeochromocytoma or paraganglioma (collectively known as PPGL) in pregnant women can lead to severe complications and death due to associated catecholamine…”
Get full text
Journal Article -
18
SDHC phaeochromocytoma and paraganglioma: A UK‐wide case series
Published in Clinical endocrinology (Oxford) (01-04-2022)“…Objective Phaeochromocytomas and paragangliomas (PPGL) are rare, but strongly heritable tumours. Variants in succinate dehydrogenase (SDH) subunits are…”
Get full text
Journal Article -
19
SUN-346 Diffusion Weighted Imaging (DWI) Highlights SDHB-Related Tumours: A Radiation Free Alternative for Surveillance Imaging
Published in Journal of the Endocrine Society (30-04-2019)“…Background There is general consensus that asymptomatic carriers of SDHB mutations should undergo periodic surveillance imaging. It is established that 68…”
Get full text
Journal Article -
20
Alpha blockade—not to be underdone
Published in Clinical endocrinology (Oxford) (01-02-2017)Get full text
Journal Article